ArticleBioactive materials2024

Engineered M2 macrophage-derived extracellular vesicles with platelet membrane fusion for targeted therapy of atherosclerosis.

Lan Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.